Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Price & Market Data

Price: $11.43

Daily Change: +$0.39 / 3.41%

Daily Range: $10.98 - $11.81

Market Cap: $202,727,792

Daily Volume: 262,873

Performance Metrics

1 Week: 7.12%

1 Month: 12.28%

3 Months: 44.32%

6 Months: 8.65%

1 Year: 59.64%

YTD: 40.42%

About Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Your daily market report for Corbus Pharmaceuticals Holdings, Inc. (CRBP). Price: 11.43, daily change: +$0.39 / 3.41%. Market cap: 202,727,792. Full performance analysis from YTD to 52-week.

Company Details

Employees: 36

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Selected stocks

Immersion Corporation (IMMR)

BRC Group Holdings, Inc. - Depositary Shares, each representing a 1/1000th fractional interest in a share of Series B Cumulative Perpetual Preferred Stock (RILYL)

NCS Multistage Holdings, Inc. (NCSM)

Chain Bridge Bancorp, Inc. (CBNA)

RLX Technology Inc. (RLX)